Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1989
11/16/1989WO1989010938A1 Protein micelles
11/16/1989WO1989010936A1 Gene for encoding a human malaria vaccine antigen
11/16/1989WO1989010755A1 Immunogenic complex and its use in vaccination
11/16/1989WO1989010754A1 Therapeutic methods using catalytic antibodies
11/16/1989WO1989010753A1 An agent for desensitizing man and/or animals against an allergen
11/16/1989WO1989010735A1 Probursin
11/16/1989WO1989009621A3 Compounds for diagnosis and/or therapy of tumours
11/15/1989EP0342128A1 Papillomavirus probes (HPV49, HPV50, HPV54, HPV55), products genetically and immunologically related to this papillomavirus and in vitro methods for the diagnosis of papillomavirus infections and for the production of antibodies against these papillomaviruses
11/15/1989EP0342015A2 Peptides, their use and pharmaceutical compositions containing them
11/15/1989EP0341746A2 Expression of hepatitis B S and preS2 proteins in methylotrophic yeasts
11/15/1989EP0341684A2 Human monoclonal antibody, hybridoma producing the same and pharmaceutical
11/15/1989EP0341611A2 Subunit canine parvovirus vaccine and method of making the same
11/15/1989EP0341304A1 Improved ricin molecules and ricin toxin conjugates
11/15/1989EP0341303A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells
11/15/1989EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/15/1989CN1037174A Novel revombinant and chimeric antibodies directed against human adenocarcinoma
11/14/1989US4880626 Immunology, vaccines
11/14/1989CA1262847A1 Silicon implant devices
11/08/1989EP0341066A2 Immunostimulating guanine derivatives, compositions and methods
11/08/1989EP0341065A2 Immunostimulating guanine dervatives, compositions and methods
11/08/1989EP0340837A1 Recombinant GAG precursor of HIV, product, process, and use as aids vaccine
11/08/1989EP0340806A2 Synthesis of human virus antigens by yeast
11/08/1989EP0340793A2 Endowing cells with antibody specificity
11/08/1989EP0340604A2 Monoclonal antibody and its use
11/08/1989EP0185042B1 Vaccine against diseases due to micro-organisms such as mycoplasms, preparation thereof and membranes of micro-organisms as active principle
11/08/1989CN1036988A Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/1989US4879225 Enhanced production of antibodies utilizing insolubilized immune complexes
11/07/1989US4879219 Immunoassay utilizing monoclonal high affinity IgM antibodies
11/07/1989US4879215 Nondiffusive binding, migration by capillary action
11/07/1989US4879213 Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
11/07/1989US4879212 Peptide composition and method for the detection of antibodies to HTLV-III
11/07/1989US4879113 Vaccine for immunologically mediated nutritional disturbances associated with plant protein antigens
11/07/1989US4879110 Antihypertensive hyperimmune milk, production, composition, and use
11/07/1989CA1262799A1 Broad spectrum vaccine against gonorrhea
11/02/1989WO1989010416A1 PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
11/02/1989WO1989010412A1 Detection of neu gene expression and products
11/02/1989WO1989010405A1 Chimeric glycoproteins containig immunogenic segments of human parainfluenza virus type 3
11/02/1989WO1989010348A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
11/02/1989WO1989010142A1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
11/02/1989WO1989010141A1 Therapeutic enzymes
11/02/1989WO1989010140A1 Further improvements relating to drug delivery systems
11/02/1989WO1989010139A1 Preparation with antibody activity and broad spectrum
11/02/1989WO1989010138A1 Physiological active liquid allergenic composition from biological raw materials
11/02/1989EP0340198A1 Immunoassay for the detection of alpha-haloacetamides
11/02/1989EP0340109A2 Anti-T-cell receptor determinants as autoimmune disease treatment
11/02/1989EP0340002A1 A human-human hybridoma derived monoclonal antibody, and the use thereof
11/02/1989EP0339695A2 A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
11/02/1989EP0339668A2 Hepatitis A virus antigen
11/02/1989EP0339667A2 Hepatitis A,B,-combined adjuvanted vaccine
11/02/1989EP0339656A2 Undenatured whey protein concentrate
11/02/1989EP0339567A1 Expression of Hepatitis B PreS 2 Protein in Methylotrophic Yeasts
11/02/1989EP0339531A1 Physiological active liquid allergenic composition from biological raw materials
11/02/1989EP0339505A2 Monoclonal antibodies to tissue plasminogen activator (t-PA) which prolong its functional half-life
11/02/1989EP0339504A2 Human immunodeficiency virus (HIV) env-coded peptide capable of eliciting HIV-inhibiting antibodies in mammals
11/02/1989EP0339443A2 Monoclonal antibody for the selective immune determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
11/02/1989EP0339389A1 Test device
11/02/1989EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production
11/01/1989CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells
10/1989
10/31/1989US4877868 Radionuclide antibody coupling
10/31/1989US4877866 Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation
10/31/1989US4877737 Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
10/31/1989US4877613 Precipitation of surface polysaccharide by complexing with cationic compound
10/31/1989US4877612 Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
10/31/1989US4877611 Vaccine containing tumor antigens and adjuvants
10/31/1989US4877610 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
10/31/1989CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention
10/26/1989DE3812181A1 Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung A medicament containing natural and / or chemically modified mono- or polysaccharides and the use thereof
10/25/1989EP0338846A2 Monoclonal antibodies
10/25/1989EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen
10/25/1989EP0338745A1 Method for producing recombinant DNA proteins
10/25/1989EP0338620A1 Recovery of hepatitis B surface antigen
10/25/1989EP0338566A2 Pertussis toxoid vaccine
10/25/1989EP0338453A2 A method of sensitization of small animals to the infection of human retroviruses
10/25/1989EP0338437A2 Synthetic vaccins against foot and mouth disease and their preparation process
10/25/1989EP0338436A2 Monoclonal antibody against neuropeptide Y, method for its preparation as well as its use
10/25/1989EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use
10/25/1989EP0338265A2 Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine
10/25/1989EP0338229A1 Preparation with antibody activity and a large spectrum of action, remedy consisting of or containing it and its use for the treatment of bacterial or toxin-induced diseases and for combatting protozoa
10/25/1989EP0338170A1 Immunoprotective antigenic protein against pathogenic bacteria
10/25/1989EP0338169A1 Method for obtaining protective antigens against bordetella infections and toxic processes
10/25/1989EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2?
10/24/1989US4876089 Envelope glycoprotein
10/24/1989US4876088 Gamma-globulin injectable solutions containing sorbitol
10/24/1989CA1262442A1 Anticariogenic or antiperiodontitic agent
10/19/1989WO1989009936A1 Isoferritin as a marker for pathological pregnancy
10/19/1989WO1989009825A1 Method for producing recombinant dna proteins
10/19/1989WO1989009818A1 Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides
10/19/1989WO1989009817A1 Composition and method for acceleration of clot lysis
10/19/1989WO1989009815A1 Novel virus of the hiv-2 family and methods of detection therefor
10/19/1989WO1989009790A1 Monoclonal antibody to enteroviruses
10/19/1989WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them
10/19/1989WO1989009787A2 Osteogenic devices
10/19/1989WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation
10/19/1989WO1989009622A1 Il-2 receptor-specific chimeric antibodies
10/19/1989WO1989009621A2 Compounds for diagnosis and/or therapy of tumours
10/19/1989WO1989009620A1 Drug for treating cancer, aids and viral diseases
10/19/1989WO1989009619A1 Method and means for immuno-stimulating blood treatment with mitogen
10/19/1989WO1989009618A1 Method for controlling hiv infectivity and vaccines for use therein
10/19/1989WO1989009617A1 A pasteurella vaccine
10/19/1989WO1989009602A1 An anti-inflammatory factor, method of isolation, and use
1 ... 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 ... 1823